Our team provides ongoing guidance, monitoring, and support to help patients build sustainable habits while working toward meaningful weight loss and improved overall health
Semaglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated neuroprotective potential
How long until results appear
Monitor your energy levels and weight to avoid underfueling, and coordinate closely with your prescribing provider. During the first few weeks after switching: You might experience some mild digestive symptoms again, similar to when you first started semaglutide Your healthcare provider may want to monitor your blood sugar more closely if you have diabetes Your weight loss may temporarily slow as your body adjusts to the new medication Just like when you started semaglutide, you'll gradually increase your tirzepatide dose over several months until you reach the target maintenance dose that works best for you
In their paper on the study, published in JAMA Ophthalmology , the researchers noted that the substantially increased risk of NAION observed in patients on semaglutide appears not to be due to differences in baseline characteristics between the cohorts. They proposed the possibility that expression of the GLP-1 receptor in the human optic nerve and GLP-1 RA-induced enhanced sympathetic nervous system activity might influence optic nerve head perfusion and potentially increase the risk of NAION. Another notable finding was that the greatest risk of NAION appeared to be within the first year following the prescription of semaglutide, a temporal association that supports a potential drug-induced risk of NAION, the researchers pointed out
[1] [3] Additionally, Ozempic slows gastric emptying, which helps to moderate post-prandial glucose spikes and promotes satiety, often leading to weight lossa beneficial effect for many patients with type 2 diabetes
